NM_014946.4:c.1414-1G>C
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_014946.4(SPAST):c.1414-1G>C variant causes a splice acceptor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_014946.4 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Publications
- hereditary spastic paraplegia 4Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Illumina, Genomics England PanelApp, Ambry Genetics
- Charlevoix-Saguenay spastic ataxiaInheritance: AR Classification: DEFINITIVE Submitted by: G2P
- neurodevelopmental disorderInheritance: AD Classification: STRONG Submitted by: G2P
- SPAST-related motor disorderInheritance: AR Classification: STRONG Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_014946.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SPAST | NM_014946.4 | MANE Select | c.1414-1G>C | splice_acceptor intron | N/A | NP_055761.2 | |||
| SPAST | NM_001363823.2 | c.1411-1G>C | splice_acceptor intron | N/A | NP_001350752.1 | ||||
| SPAST | NM_199436.2 | c.1318-1G>C | splice_acceptor intron | N/A | NP_955468.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SPAST | ENST00000315285.9 | TSL:1 MANE Select | c.1414-1G>C | splice_acceptor intron | N/A | ENSP00000320885.3 | |||
| SPAST | ENST00000621856.2 | TSL:1 | c.1411-1G>C | splice_acceptor intron | N/A | ENSP00000482496.2 | |||
| SPAST | ENST00000713716.1 | c.1519-1G>C | splice_acceptor intron | N/A | ENSP00000519019.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia 4 Pathogenic:2
For these reasons, this sequence change has been classified as Pathogenic. A Spanish hereditary spastic paraplegia (HSP) cohort study found this variant in one individual affected with uncomplicated HSP (age of onset was 30 years). cDNA synthesized from the patient was used to demonstrate that this sequence change results in skipping of exon 12 (PMID:  20932283), which is part of the the functionally important AAA domain in SPAST. This sequence change has been reported in the literature and is not present in population databases. This sequence change affects a acceptor splice site in intron 11 and is expected to disrupt mRNA splicing.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at